Podcast

0.75 CME/CE Credit

PrEParing for the Future: Overcoming Barriers and Empowering Primary Care Clinicians in HIV Prevention

While the United States has made remarkable strides in HIV prevention, treatment, and care, there remains untapped potential, especially in primary care. In 2019, a staggering 1 in 8 individuals living with HIV remained unaware of their status, while countless individuals who could benefit from Pre-Exposure Prophylaxis (PrEP) have yet to embrace its life-saving potential. Join James Simmons, DNP, MSN, RN, AG/ACNP-BC and moderator Aniruddha Hazra, MD in this engaging podcast as they shed light on the barriers that impede individuals from accessing crucial HIV services and illuminate practical strategies to overcome them. Delve into the latest breakthroughs in HIV prevention, with a particular focus on PrEP, and unlock a treasure trove of resources to empower primary care clinicians in delivering exceptional care. Together, let's seize this opportunity to bridge the gaps, ignite change, and revolutionize the landscape of HIV care in the United States.

The marks “CDC” and “Let’s Stop HIV Together” are owned by the US Dept. of Health and Human Services and used with permission. Use of these logos is not an endorsement by HHS or CDC of any particular product, service, or enterprise.

Begin

Already listened on another platform?

CME/CE Information

0.75 AMA PRA Category 1 Credits™

Release Date: 3/21/2024

Expiration Date: 3/21/2025

Topics

Learning Objectives

Describe barriers that keep people from seeking HIV services and how to overcome these barriers
Discuss advances in HIV prevention, specifically PrEP
Outline resources available for primary care clinicians to help in the uptake of HIV-related services across prevention, screening, treatment, and specialty care

Glossary

Faculty

James Simmons, DNP, MSN, RN, AG/ACNP-BC

Clinical Ambassador - Center for Disease Control and Prevention (CDC) “Let’s Stop HIV Together” Initiative

Learn More

Aniruddha (Anu) Hazra, MD

Assistant Professor, Section of Infectious Diseases and Global Health, The University of Chicago, Chicago, IL

Director, STI Services, Chicago Center of HIV Elimination

Learn More

Disclosures

The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.

James Q. Simmons, DNP, MSN, RN, AG/ACNP-BC: No relevant financial relationships disclosed.

Moderator: Aniruddha Hazra, MD: Gilead Sciences: Grant/Research Support.

Non-faculty contributors involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.

CME/CE Information

AMA PRA Category 1 Credits™

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute and CDC’s Let’s Stop HIV Together (Together) National Partnerships Team (NPT). Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Education Partner

Centers for Disease Control and Prevention

Fine Print

Computer System Requirements

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Statement of Independence

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Disclosure Policies and Contacting Pri-Med Institute

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.